114 related articles for article (PubMed ID: 1962913)
1. Severe cytomegalovirus infection and immunosuppressive therapy in pediatric liver transplantation.
Pehlivanoğlu E; Ament ME; Spolidoro JV; Vargas J; Busuttil R; Berquist WE
Turk J Pediatr; 1990; 32(1):3-11. PubMed ID: 1962913
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
[TBL] [Abstract][Full Text] [Related]
3. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
[TBL] [Abstract][Full Text] [Related]
5. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
[TBL] [Abstract][Full Text] [Related]
6. [Cytomegalovirus in liver transplantation: incidence and groups at risk].
Schiffer V; Mentha G; Giostra E; Belli D; Le Coultre C; Rohner A
Schweiz Med Wochenschr; 1994 Apr; 124(15):631-6. PubMed ID: 8191266
[TBL] [Abstract][Full Text] [Related]
7. Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation.
Cooper DK; Novitzky D; Schlegel V; Muchmore JS; Cucchiara A; Zuhdi N
J Heart Lung Transplant; 1991; 10(5 Pt 1):656-62; discussion 662-3. PubMed ID: 1659901
[TBL] [Abstract][Full Text] [Related]
8. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients.
Grossi P; Minoli L; Percivalle E; Irish W; Vigano M; Gerna G
Transplantation; 1995 Mar; 59(6):847-51. PubMed ID: 7701579
[TBL] [Abstract][Full Text] [Related]
9. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
[TBL] [Abstract][Full Text] [Related]
10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
Ahsan N; Holman MJ; Yang HC
Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
[TBL] [Abstract][Full Text] [Related]
12. Late cytomegalovirus disease following liver transplantation.
Shibolet O; Ilan Y; Kalish Y; Safadi R; Ashur Y; Eid A; Shouval D; Wolf D
Transpl Int; 2003 Dec; 16(12):861-5. PubMed ID: 12904846
[TBL] [Abstract][Full Text] [Related]
13. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
14. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
16. [Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney].
Slavicek J; Puretić Z; Glavas-Boras S; Smalcelj R; Barisić I; Vuković J; Seso-Simić D; Slavicek V; Humar I; Kes P
Acta Med Croatica; 2003; 57(1):87-90. PubMed ID: 12876872
[TBL] [Abstract][Full Text] [Related]
17. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation.
Lianghui G; Shusen Z; Tingbo L; Yan S; Weilling W; Anwei L
Transplant Proc; 2004 Jun; 36(5):1502-5. PubMed ID: 15251371
[TBL] [Abstract][Full Text] [Related]
18. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
[TBL] [Abstract][Full Text] [Related]
20. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
